Uneingeschränkter Zugang

Heat shock protein 60 and asthma treatment 10.5372/1905-7415.0604.084


Zitieren

1. Calderwood SK, Mambula SS, Gray PJ Jr. Extracellular heat shock proteins in cell signaling and immunity. Ann NY Acad Sci. 2007; 1113:28-39.10.1196/annals.1391.01917978280Search in Google Scholar

2. V, Hauet-Broere F, Berlo S, Paul L, van der Zee R, de Kleer I,et al. Stress proteins as inducers and targets of regulatory T cells in arthritis. Int Rev Immunol. 2005; 24:181-97.10.1080/0883018059093495816036373Open DOISearch in Google Scholar

3. Pockley AG, Muthana M, Calderwood SK. The dual immunoregulatory roles of stress proteins. Trends Biochem Sci. 2008; 33:71-9.10.1016/j.tibs.2007.10.00518182297Search in Google Scholar

4. Gupta RS, Ramachandra NB, Bowes T, Singh B. Unusual cellular disposition of the mitochondrial molecular chaperones Hsp60, Hsp70 and Hsp10. Novartis Found Symp. 2008; 291:59-68.10.1002/9780470754030.ch518575266Search in Google Scholar

5. Merendino AM, Bucchieri F, Campanella C, Marcian V, Ribbene A, David S, et al. Hsp60 is actively secreted by human tumor cells. Plos One. 2010; 5:e9247.10.1371/journal.pone.0009247282192220169074Open DOISearch in Google Scholar

6. Ramage JM, Young JL, Goodall JC, Gaston JS. T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes. J Immunol. 1999; 162: 704-10.10.4049/jimmunol.162.2.704Search in Google Scholar

7. Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol, 2007; 292:H3052-6.10.1152/ajpheart.01355.200617307989Search in Google Scholar

8. A Kol, T Bourcier, A Lichtman, P Libby. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages, J Clin Invest. 1999; 103:571-7.Search in Google Scholar

9. A Kol, AH Lichtman, RW Finberg, P Libby, EA Kurt- Jones. Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 2000; 164:13-7.10.4049/jimmunol.164.1.1310604986Search in Google Scholar

10. Li YY, Ochs S, Gao ZR, Malo A, Chen CJ, Lv S, et al. Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2009; 297:G981-9.10.1152/ajpgi.00225.200920501446Search in Google Scholar

11. Cappello F, de Macario EC, Marasà L, Zummo G, Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther. 2008; 7:801-9.10.4161/cbt.7.6.628118497565Open DOISearch in Google Scholar

12. Kleer IM, Kamphuis SM, Rijkers GT, Scholtens L, Gordon G, De Jager W, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum. 2003; 48: 2001-10.10.1002/art.1117412847694Search in Google Scholar

13. Zanin-Zhorov A, Bruck R, Tal G, Oren S, Aeed H, Hershkoviz R, et al. Heat Shock Protein 60 Inhibits Th1-Mediated Hepatitis Model via Innate Regulation of Th1/Th2 Transcription Factors and Cytokines. J Immunol. 2005; 174:3227-36.10.4049/jimmunol.174.6.3227Search in Google Scholar

14. Anderton SM, van der Zee R, Prakken B, Noordzij A, van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. Exp Med. 1995; 181:943-52.10.1084/jem.181.3.943Search in Google Scholar

15. Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de Graeff-Meeder ER, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 1996; 39:1826-32.10.1002/art.1780391108Search in Google Scholar

16. van Roon JA, van Eden W, van Roy JL, Lafeber FJ, Bijlsma JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest. 1997; 100:459-63.10.1172/JCI119553Search in Google Scholar

17. Quintana FJ, Carmi P, Cohen IR. DNA vaccination with heat shock protein 60 inhibits cyclophosphamideaccelerated diabetes. J Immunol 2002; 169:6030-5.10.4049/jimmunol.169.10.6030Search in Google Scholar

18. Quintana FJ, Carmi P, Mor F, Cohen IR. DNA fragments of human HSP60 vaccinate against adjuvant arthritis: Identification of a regulatory HSP60 peptide. J Immunol. 2003; 171:3533-41.10.4049/jimmunol.171.7.3533Search in Google Scholar

19. Huurman VA, van der Meide PE, Duinkerken G, Willemen S, Cohen IR, Elias D, et al. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol. 2008; 152: 488-97.10.1111/j.1365-2249.2008.03656.xSearch in Google Scholar

20. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet. 2001; 358:1749-53.10.1016/S0140-6736(01)06801-5Search in Google Scholar

21. Delaleu N, Madureira AC, Immervoll H, Jonsson R. Inhibition of experimental Sjo¨gren’s syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum. 2008;58: 2318-28.10.1002/art.2365618668586Search in Google Scholar

22. Anne-Marie Madore, St phanie Perron, V ronique Turmel, Michel Laviolette, lyse Y, Bissonnette, et al. Alveolar macrophages in allergic asthma: An expression signature characterized by heat shock protein pathways Hum Immunol. 2010; 71:144-50.Search in Google Scholar

23. Zanin-Zhorov A, Cahalon A, Tal G, Margalit R, Lider O, Cohen IR. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest. 2006; 116:2022-32.10.1172/JCI28423147481916767222Search in Google Scholar

24. Zanin-Zhorov A, Nussbaum G, Franitza S, Cohen IR, LiderO. T lymphocytes respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 2003;17: 1567-9.10.1096/fj.02-1139fje12824285Search in Google Scholar

25. Osterloh A, Veit A, Gessner A, Fleischer B, Breloer M. Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12. Int Immunol. 2008; 20:433-43.10.1093/intimm/dxn00318256040Open DOISearch in Google Scholar

26. Guan Y, Omueti-Ayoade K, Mutha SK, Hergenrother PJ, Tapping RI. Identification of novel synthetic tolllike receptor 2 agonists by high throughput screening. J Biol Chem. 2010; 285:23755-62.10.1074/jbc.M110.116046291129420504771Search in Google Scholar

27. O’Neill LA. Primer: Toll-like receptor signaling pathways-what do rheumatologists need to know? Nat Clin Pract Rheumatol. 2008; 4:319-27. 10.1038/ncprheum080218446139Open DOISearch in Google Scholar

28. Burns E, Eliyahu T, Uematsu S. TLR2-Dependent Inflammatory Response to Porphyromonas gingivalis Is MyD88 Independent, whereas MyD88 Is Required To Clear Infection. J Immunol. 2010; 184:1455-62.10.4049/jimmunol.090037820042569Search in Google Scholar

29. O’Neill LA, Bryant CE, Doyle SL. Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer. Pharmacol Rev. 2009; 61:177-97.10.1124/pr.109.001073284615619474110Search in Google Scholar

30. Chen BC, Kang JC, Lu YT, Hsu MJ, Liao CC, Chiu WT, et al. Rac1 regulates peptidoglycan-induced nuclear factor-κB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway. Mol Immunol.2009; 46:1179-8810.1016/j.molimm.2008.11.00619118901Search in Google Scholar

31. Dechene L: TH1/TH2 immune response. J Allergy Clin Immunol. 2002; 110:539-40.10.1067/mai.2002.12743612209115Search in Google Scholar

32. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 +T lymphocytes regulates tissue in flammation by producing interleukin 17. Nat Immunol. 2005; 6:1133-41.10.1038/ni1261161887116200068Open DOISearch in Google Scholar

33. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax. 2005; 60:529-30.Search in Google Scholar

34. Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, Bhagat G, et al. A signaling pathway mediating down regulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell. 2007; 12:280-92.10.1016/j.ccr.2007.08.01117785208Open DOISearch in Google Scholar

35. Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, et al. Novel NEMO/IkappaB kinase and NFkappa B target genes at the pre-B to immature B cell transition. J Biol Chem. 2001; 276:18579-90.10.1074/jbc.M10084620011279141Search in Google Scholar

36. Reynolds JM, Pappu BP, Peng J, Martinez GJ, Zhang Y, Chung Y, et al. Toll-like Receptor 2 Signaling in CD4(+) T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease. Immunity. 2010; 32:692-702.10.1016/j.immuni.2010.04.010287891720434372Open DOISearch in Google Scholar

37. Zanin-Zhorov A, Tal G, Shivtiel S, Cohen M, Lapidot T, Nussbaum G, et al. Heat Shock Protein 60 Activates Cytokine-Associated Negative Regulator Suppressor of Cytokine Signaling 3 in T lymphocytes: Effects on Signaling, Chemotaxis, and Inflammation. J Immunol. 2005; 175:276-85.10.4049/jimmunol.175.1.27615972659Search in Google Scholar

38. Quintana FJ, Mimran A, Carmi P, Mor F, Cohen IR. HSP60 as a target of anti-ergotypic regulatory T cells. PLoS One. 2008;3:e4026.10.1371/journal.pone.0004026260285219107191Open DOISearch in Google Scholar

39. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogenactivated protein kinase and c-Fos in dendritic cells. J Immunol. 2004; 172:4733-43.10.4049/jimmunol.172.8.473315067049Search in Google Scholar

40. Redecke V, Häcker H, Datta SK, Fermin A, Pitha PM, Broide DH. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol. 2004; 172: 2739-43. 10.4049/jimmunol.172.5.273914978071Search in Google Scholar

eISSN:
1875-855X
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
6 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Gesundheitsfachberufe, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin